SLC1A5 and head and neck squamous cell carcinoma: In vivo, HNSCC cell growth was inhibited by silencing ASCT2 or the addition of cetuximab alone compared with that in the control group, and the combination of cetuximab and shASCT2 remarkably suppressed SCC15 and FaDu xenografts (Fig. 6e).